Fei Su
Impact in
- Geriatrics and Gerontology top 0.1%
- Sirtuins and Resveratrol in Medicine
- Aging top 2%
Papers in
-
- Genomics and Phylogenetic Studies 4
- Gut microbiota and health 3
- Metabolomics and Mass Spectrometry Studies 3
- Oncology 16
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Wei Gu (2 shared papers)Delin Chen (2 shared papers)Jianyuan Luo (2 shared papers)Leonard Guarente (1 shared paper)Anatoly Nikolaev (1 shared paper)Shin‐ichiro Imai (1 shared paper)Robert J. Schneider (3 shared papers)Margherita Doria (1 shared paper)
- Journals
- Journal of Bacteriology (5 papers)Journal of Clinical Oncology (3 papers)Annals of Oncology (2 papers)Human Vaccines & Immunotherapeutics (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Fei Su
65 papers receiving 3.8k citations
Fei Su's Hit Papers
Peers
Comparison fields: 5 of 118
- Geriatrics and Gerontology 1.2k
- Aging 133
- Physiology 208
- Oncology 829
- Epidemiology 1.0k
Countries citing papers authored by Fei Su
This map shows the geographic impact of Fei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Su more than expected).
Fields of papers citing papers by Fei Su
This network shows the impact of papers produced by Fei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Su. The network helps show where Fei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Negative Control of p53 by Sir2α Promotes Cell Survival under Stress Hit paper breakdown → | 2001 | 1808 |
| 2 | Deacetylation of p53 modulates its effect on cell growth and apoptosis Hit paper breakdown → | 2000 | 684 |
| 3 | 1997 | 261 | |
| 4 | 1996 | 253 | |
| 5 | 2001 | 96 | |
| 6 | 2012 | 72 | |
| 7 | 2017 | 46 | |
| 8 | 2015 | 41 | |
| 9 | 2022 | 39 | |
| 10 | 2008 | 33 | |
| 11 | 2018 | 32 | |
| 12 | 2019 | 28 | |
| 13 | 2018 | 28 | |
| 14 | 2014 | 22 | |
| 15 | 2011 | 20 | |
| 16 | 2021 | 20 | |
| 17 | 2014 | 20 | |
| 18 | 2011 | 19 | |
| 19 | 2012 | 19 | |
| 20 | 2024 | 18 |
About Fei Su
Fei Su is a scholar working on Molecular Biology, Oncology, Epidemiology, Pulmonary and Respiratory Medicine and Food Science, having authored 68 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Genomics and Phylogenetic Studies (4 papers), Gut microbiota and health (3 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). The work is most often cited by research in Geriatrics and Gerontology (1.2k citations), Aging (133 citations), Physiology (208 citations), Oncology (829 citations) and Epidemiology (1.0k citations). Fei Su has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Wei Gu, Delin Chen, Jianyuan Luo, Leonard Guarente, Anatoly Nikolaev, Shin‐ichiro Imai, Robert J. Schneider, Margherita Doria, Baoquan Liu and Fei Xiao. Their work appears in journals such as Journal of Bacteriology, Journal of Clinical Oncology, Annals of Oncology, Human Vaccines & Immunotherapeutics and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.